ESMO Gastrointestinal Oncology is the European Society for Medical Oncology's latest peer-reviewed open access journal, dedicated to publishing high-quality research and commenting on all aspects of the diagnosis, treatment and understanding of gastrointestinal cancers.The journal aims to publish experimental, translational, diagnostic and therapeutic research. Specific areas of interest include but are not limited to gastrointestinal cancer biology and epidemiology, prevention and early detection, advances in molecular, genetic and imaging diagnostics, therapeutic studies from pre-clinical to clinical (phase I-IV) with a focus on targeted and immunotherapy, translational research, patient-oriented studies, psychosocial aspects of disease, treatment of long-term morbidity and survivorship, palliative and supportive care, novel methods and clinical protocols. The journal welcomes original articles, reviews, mini reviews, editorials, research methods and clinical trial summaries, and correspondence. In addition, it provides in-depth commentaries from leading experts and engages in active debate on important topics via its pro and con discussion section.ESMO Gastrointestinal Oncology is committed to providing swift review and publication supported by our team of experienced international experts and key opinion leaders. The journal will provide essential reading for cancer researchers, clinician-scientists, clinicians with a focus gastrointestinal cancer, patient advocates and all health care professionals with a specific interest in gastrointestinal cancers. The journal rapidly disseminates the best innovative clinical and translational research and aims to improve the quality of education, prevention, diagnosis, treatment and patient care worldwide.
Pancreatology is the official journal of the International Association of Pancreatology (IAP), the European Pancreatic Club (EPC) and several national societies and study groups around the world. Dedicated to the understanding and treatment of exocrine as well as endocrine pancreatic disease, this multidisciplinary periodical publishes original basic, translational and clinical pancreatic research from a range of fields including gastroenterology, oncology, surgery, pharmacology, cellular and molecular biology as well as endocrinology, immunology and epidemiology. Readers can expect to gain new insights into pancreatic physiology and into the pathogenesis, diagnosis, therapeutic approaches and prognosis of pancreatic diseases. The journal features original articles, case reports, consensus guidelines and topical, cutting edge reviews, thus representing a source of valuable, novel information for clinical and basic researchers alike.
The Lancet Gastroenterology & Hepatology is an authoritative forum for key opinion leaders across medicine, government, and health systems to influence clinical practice, explore global policy, and inform constructive, positive change worldwide. The journal publishes original research, expert review, opinion, and news covering international issues, providing a clear, independent perspective about the clinical advances and practice-changing research shaping these specialties globally.The Lancet Gastroenterology & Hepatology publishes papers that reflect the rich variety of ongoing clinical research in these fields, especially in the areas of inflammatory bowel diseases, NAFLD and NASH, functional gastrointestinal disorders, digestive cancers, and viral hepatitis.